VolFlashVOLFLASH
中文Sign inUpgrade
Low 40 Corporate wallstcn · 2026-11-05 21:46 (Asia/Shanghai)

ZaiZhi Medicine Q3 Report: Global Pipeline Accelerates; China Commercialization Improves Sequentially, Maintaining Profitability; Growth Expected to Resume in 2027

Zai Lab reported third-quarter total revenue of $108.2 million, including product revenue of $107.6 million, down 7% year-on-year and up 2% quarter-on-quarter. The sequential improvement was driven by

Read source ↗
VolFlash analysisQueued

This event is in the analysis queue — usually done within 40s. Refresh to see it.

One email a day — don't miss the big ones

The 8 highest-severity events of the past 24h, with our read and source links. Unsubscribe anytime.

Related events
11-05 21:40 US Average Hourly Earnings m/m Due Nov. 6 at 21:30 🔒 11-06 01:34 SpaceX 5-Year CDS Widens 24.5 Bps to 286.56, a Record High 🔒 11-06 11:56 ZTE Corp., NewEase, Luxshare, Dongshan Precision, TFC, Hygon Info and others ann 🔒 11-05 18:04 SSE Holds Special Seminar on M&A and Restructuring 🔒

Published：2026-11-05 21:46:29 · Source：wallstcn · Automatically aggregated and analysed — verify against the original source.